Opportunities and Challenges for Inhalable Nanomedicine Formulations in Respiratory Diseases: A Review
Xujun Feng,Yuan Shi,Ye Zhang,Fei Lei,Rong Ren,Xiangdong Tang
DOI: https://doi.org/10.2147/ijn.s446919
IF: 7.033
2024-02-17
International Journal of Nanomedicine
Abstract:Xujun Feng, Yuan Shi, Ye Zhang, Fei Lei, Rong Ren, Xiangdong Tang Department of Respiratory and Critical Care Medicine, Sleep Medicine Center, Mental Health Center, West China Hospital, Sichuan University, Chengdu, People's Republic of China Correspondence: Rong Ren; Xiangdong Tang, Department of Respiratory and Critical Care Medicine, Sleep Medicine Center, Mental Health Center, West China Hospital, Sichuan University, Dian Xin Nan Jie 28&num, Chengdu, 610041, People's Republic of China, Tel +86-28-85422733, Email ; Lungs experience frequent interactions with the external environment and have an abundant supply of blood; therefore, they are susceptible to invasion by pathogenic microorganisms and tumor cells. However, the limited pharmacokinetics of conventional drugs in the lungs poses a clinical challenge. The emergence of different nano-formulations has been facilitated by advancements in nanotechnology. Inhaled nanomedicines exhibit better targeting and prolonged therapeutic effects. Although nano-formulations have great potential, they still present several unknown risks. Herein, we review the (1) physiological anatomy of the lungs and their biological barriers, (2) pharmacokinetics and toxicology of nanomaterial formulations in the lungs; (3) current nanomaterials that can be applied to the respiratory system and related design strategies, and (4) current applications of inhaled nanomaterials in treating respiratory disorders, vaccine design, and imaging detection based on the characteristics of different nanomaterials. Finally, (5) we analyze and summarize the challenges and prospects of nanomaterials for respiratory disease applications. We believe that nanomaterials, particularly inhaled nano-formulations, have excellent prospects for application in respiratory diseases. However, we emphasize that the simultaneous toxic side effects of biological nanomaterials must be considered during the application of these emerging medicines. This study aims to offer comprehensive guidelines and valuable insights for conducting research on nanomaterials in the domain of the respiratory system. Keywords: nanoparticles, respiratory system, lungs, nanomaterials, nanotechnology Graphical Since frequent interactions occur between the lungs and the surrounding environment, the lungs are vulnerable to exposure to external pollutants and pathogenic microorganisms. At the same time, owing to the rich blood supply in the lungs, exposure to toxic substances or pathogenic microorganisms may lead to systemic diseases. Inhalation therapy involves drug delivery as aerosols, dry powder, or nebulized solution into the respiratory tract, which acts on the mucous membranes of the respiratory tract and alveoli. 1 Inhalation therapy is targeted and represents an important methodology for treating respiratory disorders. 2 The emergence of nanotechnology has led to the development of diverse nano-formulations, which have opened up new research avenues in the field of biomedicine. Specifically, nanotechnology can be used to create formulations that have great potential for drug delivery to the lungs. 3 Nano-formulations are expected to address the issue of inadequate lung targeting observed in traditional treatments; at the same time, they can overcome various barriers to the lungs, enhance drug solubility, and allow the drug to reach the therapeutic concentration, thus producing a better therapeutic effect. 4 Currently, many nano-formulations are being used to treat lung diseases. 5 Although nano-formulations have great potential, they still pose many unknown risks. For instance, a large body of evidence suggests that some nanoparticles (NPs) can accumulate in the lungs after inhalation and induce lung nodules or even tumors. Therefore, inhalation formulations prepared based on nanotechnology need to be evaluated for potential toxicity. 6,7 An in-depth investigation of nanopreparations at the toxicological level can help to further develop nanomedicines with better bioactivity and biosafety. 8 As nanoparticles are expected to perform a critical function in the diagnosis and management of respiratory diseases, it is of great significance to explore their bioactivity and toxicological properties at the nanoscale. Therefore, the current investigation aimed to evaluate the therapeutic and diagnostic value of various nanoparticles/formulations in the respiratory system at the nano-level, as well as to evaluate their possible toxic consequences. Throughout the present research, we first describe the anatomical and biological barriers to the respiratory tract and lungs. Subsequently, the pharmacokinetics and toxicology of nanoparticles during administration to the respiratory system are discussed, and various types of nanoparticles, includ -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology